Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
440.00    0.00 (0.00%)
Bid:
437.50
Ask:
442.50
Spread: 5.00 (1.143%)
Market Cap: £216.40m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

5 Jul 2011 07:00

RNS Number : 7555J
Zotefoams PLC
05 July 2011
 



 

Zotefoams plc

("Zotefoams" or "the Company")

Trading Update

5 July 2011 - Zotefoams, which manufactures and sells high-performance foams, today, announces its trading update for the six months ended 30 June 2011.

Like-for-like sales excluding the consolidation of MuCell Extrusion LLC ("MEL") for the six months ended 30 June 2011 are approximately 10% above that in the same period last year driven by growth in our Azote® polyolefin foam products. Revenues from our High-Performance Polymers for the first half of 2011, which depend on the phasing of relatively large shipments, are at a similar level to that experienced in the first half of 2010.

The integration of MEL, which is trading in line with our expectations, into the Zotefoams Group is now substantially complete. We are planning to invest further resource in this business to support our medium term plans for growth.

As previously reported, raw material prices have been significantly higher than the equivalent period last year with certain supply related issues caused by high levels of market demand for polymer products worldwide. This has impacted margins in the short term but now operational improvements and the benefit of sales price increases are being seen in the business.

Overall, with the benefit of higher sales levels in the first half of the year, the Company is trading in line with expectations and the Board remains confident of the Company's future prospects.

The Company will announce its interim results for the six months ended 30 June 2011 on Tuesday, 2 August 2011.

Enquiries:

 

Zotefoams plc 0208-664-1600

David Stirling, Managing Director

 

Clifford Hurst, Finance Director

 

 

Financial Dynamics Limited 0207-831-3113

 

Ben Brewerton/John Dineen

 

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces light-weight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTZMGGNNDLGMZM
Date   Source Headline
5th Jun 20172:14 pmRNSDirector/PDMR Shareholding
1st Jun 20174:30 pmRNSDirector/PDMR Shareholding
31st May 20177:00 amRNSDirector/PDMR Shareholding
17th May 20177:00 amRNSTrading Update
12th May 201711:16 amRNSDirector/PDMR Shareholding
12th Apr 20173:34 pmRNSAnnual Report and Accounts and Notice of 2017 AGM
12th Apr 20173:24 pmRNSDirector/PDMR Shareholding
12th Apr 20171:55 pmRNSHolding(s) in Company
10th Apr 20174:02 pmRNSDirector/PDMR Shareholding
6th Apr 20172:27 pmRNSHolding(s) in Company
6th Apr 20172:25 pmRNSHolding(s) in Company
28th Mar 201711:36 amRNSDirector/PDMR Shareholding
27th Mar 201710:16 amRNSHolding(s) in Company
24th Mar 20173:33 pmRNSHolding(s) in Company
23rd Mar 201710:11 amRNSHolding(s) in Company
22nd Mar 20173:28 pmRNSHolding(s) in Company
14th Mar 20175:28 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
9th Mar 20177:00 amRNSCoveris using MuCell® technology
15th Feb 201710:46 amRNSDirector/PDMR Shareholding
10th Feb 20177:00 amRNSHolding(s) in Company
1st Feb 20176:27 pmRNSHolding(s) in Company
12th Jan 20179:36 amRNSDirector/PDMR Shareholding
11th Jan 201710:33 amRNSHolding(s) in Company
10th Jan 20175:34 pmRNSHolding(s) in Company
9th Jan 20177:00 amRNSTrading Update
6th Jan 20177:00 amRNSAppointment of Joint Broker
6th Jan 20177:00 amRNSAcquires full ownership of its joint venture
22nd Dec 20164:35 pmRNSPrice Monitoring Extension
13th Dec 20161:58 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSHolding(s) in Company
15th Nov 201612:40 pmRNSDirector/PDMR Shareholding
14th Nov 201610:30 amRNSDirector Declaration
28th Oct 20167:00 amRNSThird Quarter Trading Update
25th Oct 20164:40 pmRNSSecond Price Monitoring Extn
25th Oct 20164:35 pmRNSPrice Monitoring Extension
24th Oct 201612:07 pmRNSSecond Price Monitoring Extn
24th Oct 201612:02 pmRNSPrice Monitoring Extension
20th Oct 20164:40 pmRNSSecond Price Monitoring Extn
20th Oct 20164:35 pmRNSPrice Monitoring Extension
19th Oct 20163:43 pmRNSHolding(s) in Company
18th Oct 201611:56 amRNSDirector/PDMR Shareholding
14th Oct 20164:35 pmRNSPrice Monitoring Extension
13th Oct 20164:35 pmRNSPrice Monitoring Extension
12th Oct 20165:56 pmRNSDirector/PDMR Shareholding
5th Oct 20164:29 pmRNSHolding(s) in Company
14th Sep 201611:16 amRNSDirector/PDMR Shareholding
23rd Aug 20164:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20164:35 pmRNSPrice Monitoring Extension
12th Aug 20167:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.